102 related articles for article (PubMed ID: 1350010)
1. Combined chemotherapy versus melphalan and prednisolone for treatment of myelomatosis.
Gregory WM; Richards MA; Malpas JS
Lancet; 1992 May; 339(8805):1353-4. PubMed ID: 1350010
[No Abstract] [Full Text] [Related]
2. Progress in the treatment of multiple myeloma.
Kumar S
Lancet; 2006 Mar; 367(9513):791-2. PubMed ID: 16530557
[No Abstract] [Full Text] [Related]
3. Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials.
Gregory WM; Richards MA; Malpas JS
J Clin Oncol; 1992 Feb; 10(2):334-42. PubMed ID: 1531068
[TBL] [Abstract][Full Text] [Related]
4. Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105).
Maruyama D; Iida S; Machida R; Kusumoto S; Fukuhara N; Yamauchi N; Miyazaki K; Yoshimitsu M; Kuroda J; Tsukamoto N; Tsujimura H; Usuki K; Yamauchi T; Utsumi T; Mizuno I; Takamatsu Y; Nagata Y; Ota S; Ohtsuka E; Hanamura I; Suzuki Y; Yoshida S; Yamasaki S; Suehiro Y; Kamiyama Y; Fukuhara S; Tsukasaki K; Nagai H
Cancer Sci; 2022 Sep; 113(9):3267-3270. PubMed ID: 35909244
[No Abstract] [Full Text] [Related]
5. Intermittent melphalan and prednisolone therapy in plasma cell myeloma.
Mellstedt H; Björkholm M; Holm G
Acta Med Scand; 1977; 202(1-2):5-9. PubMed ID: 899883
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy for myelomatosis.
Azam L; Delamore IW
Br Med J; 1974 Dec; 4(5944):560-4. PubMed ID: 4611585
[TBL] [Abstract][Full Text] [Related]
7. Survival in multiple myeloma in Kerala.
Nair MK; Varghese C; Krishnan E; Sankaranarayanan R; Nair B
Natl Med J India; 1993; 6(1):7-10. PubMed ID: 8453369
[TBL] [Abstract][Full Text] [Related]
8. Proceedings: Treatment of multiple myeloma by a quadruple chemotherapy regime.
Azam L; Delamore IW
Br J Haematol; 1974 Jun; 27(2):362. PubMed ID: 4843684
[No Abstract] [Full Text] [Related]
9. [Therapy of multiple myeloma. Results of sequential treatment with melphalan-prednisolone and the M2 protocol].
Steinke B; Busch FW; Stapelfeld S; Ostendorf P; Waller HD
Dtsch Med Wochenschr; 1984 Jun; 109(26):1015-9. PubMed ID: 6547386
[TBL] [Abstract][Full Text] [Related]
10. Myelomatosis: comparison of melphalan and cyclophosphamide therapy.
Br Med J; 1971 Mar; 1(5750):640-1. PubMed ID: 4926948
[TBL] [Abstract][Full Text] [Related]
11. Amyloid myopathy and myeloma: response to treatment.
Sheehan-Dare RA; Simmons AV
Postgrad Med J; 1987 Feb; 63(736):141-2. PubMed ID: 3671242
[TBL] [Abstract][Full Text] [Related]
12. Blood and neoplastic diseases. Myelomatosis.
Malpas JS
Br Med J; 1974 Nov; 4(5943):520-2. PubMed ID: 4434121
[No Abstract] [Full Text] [Related]
13. Intensive therapy for myeloma.
McElwain TJ; Meldrum M; Gore ME; Millar BC; Malpas JS
Pathol Biol (Paris); 1990 Oct; 38(8):830. PubMed ID: 2274375
[No Abstract] [Full Text] [Related]
14. Primary amyloidosis and myelomatosis associated with excessive fibrinolytic acitivty.
Millard LG; Rowell NR
Br J Dermatol; 1976 May; 94(5):569-71. PubMed ID: 1268067
[TBL] [Abstract][Full Text] [Related]
15. Multiple myeloma with coexistent myelofibrosis: improvement of myelofibrosis following recovery from multiple myeloma after treatment with melphalan and prednisolone.
Kawauchi K; Mori H; Sugiyama H; Oshimi K; Hirayama A
Jpn J Med; 1991; 30(5):483-6. PubMed ID: 1803051
[TBL] [Abstract][Full Text] [Related]
16. Response level and survival after conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study.
Oivanen TM; Kellokumpu-Lehtinen P; Koivisto AM; Koivunen E; Palva I
Eur J Haematol; 1999 Feb; 62(2):109-16. PubMed ID: 10052714
[TBL] [Abstract][Full Text] [Related]
17. Plasma melphalan and prednisolone concentrations during oral therapy for multiple myeloma.
Taha IA; Ahmad RA; Gray H; Roberts CI; Rogers HJ
Cancer Chemother Pharmacol; 1982; 9(1):57-60. PubMed ID: 7139852
[TBL] [Abstract][Full Text] [Related]
18. Melphalan plus prednisolone in the treatment of multiple myeloma.
Begum M; Akther A; Khan KH; Kaiser MS; Rahman MJ; Alam MN
Mymensingh Med J; 2012 Jan; 21(1):93-7. PubMed ID: 22314461
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with MCNU, vindesine, melphalan, and prednisolone (MCNU-VMP therapy) in induction therapy for multiple myeloma. Japan Myeloma Study Group.
Imamura Y; Takagi T; Yawata Y; Nishinarita S; Kosaka M; Mikuni C; Takatsuki K; Sezaki T; Mori M; Tsuchiya J
Int J Hematol; 1994 Feb; 59(2):113-23. PubMed ID: 8018904
[TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy in Alkeran-resistant myelomatosis].
Kjølseth I; Wisløff F; Godal HC
Tidsskr Nor Laegeforen; 1984 May; 104(13):873-4. PubMed ID: 6463973
[No Abstract] [Full Text] [Related]
[Next] [New Search]
